Ponencia

How to convince the head of department and managing director of the importance of specialised headache clinics

N. Riesco, C. García-Cabo, J. Martínez-Ramos, J. Pascual [REV NEUROL 2015;61 (Supl. 1):S0-S20] PMID: 26337642 DOI: https://doi.org/10.33588/rn.61S01.2015217

OPEN ACCESS

Volumen 61 | Number S01 | Nº of views of the article 6.444 | Nº of PDF downloads 524 | Article publication date 08/09/2015

Download PDF Castellano Citation Search in PubMed

Share in:

Go to another issue

ABSTRACT

In spite that headache is, by far, the most frequent reason for neurological consultation and that the diagnosis and treatment of some patients with headache is difficult, the number of headache clinics is scarce in our country. In this paper the main arguments which should allow us, as neurologists, to defend the necessity of implementing headache clinics are reviewed. To get this aim we should first overcome our internal reluctances, which still make headache as scarcely appreciated within our specialty. The facts that more than a quarter of consultations to our Neurology Services are due to headache, that there are more than 200 different headaches, some of them actually invalidating, and the new therapeutic options for chronic patients, such as OnabotulinumtoxinA or neuromodulation techniques, oblige us to introduce specialised headache attendance in our current neurological offer. Even though there are no definite data, available results indicate that headache clinics are efficient in patients with chronic headaches, not only in terms of health benefit but also from an economical point of view. KeywordsBotulinum toxin type A Chronic cluster headache Chronic migraine Headache clinics OnabotulinumtoxinA CategoriesCefalea y Migraña Dolor

FULL TEXT (solo disponible en lengua castellana / Only available in Spanish)

Acceso directo al último número

Último Podcast

Ponencia

How to convince the head of department and managing director of the importance of specialised headache clinics